{"id":"W3118386410","doi":"10.1016/j.clinre.2020.101604","title":"Vedolizumab for steroid & infliximab refractory immune checkpoint inhibitor associated colitis","year":2021,"lang":"en","type":"letter","venue":"Clinics and Research in Hepatology and Gastroenterology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Vedolizumab; Medicine; Infliximab; Colitis; Refractory (planetary science); Internal medicine; Pharmacology; Gastroenterology; Ulcerative colitis; Tumor necrosis factor alpha; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.002461596,0.0003708108,0.001469493,0.0005812428,0.0002040062,0.00004561971,0.0001798087,0.00217815,0.00007557175],"category_scores_gemma":[0.0006662567,0.0003407978,0.0002754886,0.0001892501,0.001473302,0.00004765552,0.000304798,0.004109403,0.000003562662],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002425428,"about_ca_system_score_gemma":0.0004409458,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002073402,"about_ca_topic_score_gemma":0.0009078767,"domain_scores_codex":[0.9950861,0.001250387,0.00115575,0.000934271,0.0002960576,0.001277478],"domain_scores_gemma":[0.9972471,0.00137043,0.0003038333,0.0005051256,0.0004209318,0.0001525839],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05159026,0.001440832,0.3927771,0.003654433,0.002534579,0.004781348,0.0007693571,1.534971e-7,0.001285677,0.00002858244,0.5254917,0.015646],"study_design_scores_gemma":[0.0171845,0.00693746,0.05974941,0.0008977138,0.000130802,0.001154571,0.0001142472,0.00006879498,0.00005294932,0.0006303572,0.9127975,0.0002817147],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6907063,0.007205065,0.00000978229,0.3000277,0.0008708298,0.000923618,0.0001832639,0.00001963646,0.00005379856],"genre_scores_gemma":[0.496637,0.05738426,0.0005603443,0.431424,0.003499299,0.001258362,0.004764714,0.0002418642,0.004230139],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3873058,"threshold_uncertainty_score":0.9999044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09002683150155434,"score_gpt":0.3890676012928184,"score_spread":0.299040769791264,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}